Cefoxitin: Clinical Trials

3 trials of Cefoxitin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting, 1 unknown. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 31Recruiting 1

Follow Cefoxitin: new trials by email Literature Review of Cefoxitin trials Research Report on Cefoxitin

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Ceftriaxone for Injection, Amoxicillin - Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection
Phase 2Not yet recruitingThe University of Queensland3002027-04-012026-03-20
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Amikacin, Tigecycline, Imipenem - Pulmonary Disease Due to Mycobacteria (Diagnosis)
Phase 2 / Phase 3RecruitingThe University of Queensland3002020-03-022026-05-11
Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries
Azithromycin 500 mg, Mefoxin 2g - Endometritis, Cesarean Section; Infection
Phase 2UnknownRWJ Barnabas Health at Jersey City Medical Center8002019-09-152019-09-17

Conditions studied

Infections (2)  ·  Mycobacterium Infections, Nontuberculous (2)  ·  Disease (1)  ·  Endometritis (1)  ·  Lung Diseases (1)  ·  Wound Infection (1)

Sponsors

The University of Queensland (2)  ·  RWJ Barnabas Health at Jersey City Medical Center (1)

Countries

Australia (1)  ·  Denmark (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Singapore (1)  ·  Taiwan (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Tali Wajsfeld, MD (1)